The adjusted subhazard ratio (aSHR) revealed that GLP-1 RA use had a lower aSHR for stroke, ischemic stroke, hemorrhagic stroke, a neutral effect on CAD and heart failure, and a higher aSHR for arrhythmia (Figure 1 and Figure 2, Table 2). This evidence concerns the gene GLP1R and Stroke.